Below are the most recent publications written about "Mullerian Ducts" by people in Profiles.
-
Lofrano-Porto A, Pereira SA, Dauber A, Bloom JC, Fontes AN, Asimow N, de Moraes OL, Araujo PAT, Abreu AP, Guo MH, De Oliveira SF, Liu H, Lee C, Kuohung W, Coelho MS, Carroll RS, Jiang R, Kaiser UB. OSR1 disruption contributes to uterine factor infertility via impaired M?llerian duct development and endometrial receptivity. J Clin Invest. 2023 12 01; 133(23).
-
Saatcioglu HD, Kano M, Horn H, Zhang L, Samore W, Nagykery N, Meinsohn MC, Hyun M, Suliman R, Poulo J, Hsu J, Sacha C, Wang D, Gao G, Lage K, Oliva E, Morris Sabatini ME, Donahoe PK, P?pin D. Single-cell sequencing of neonatal uterus reveals an Misr2+ endometrial progenitor indispensable for fertility. Elife. 2019 06 24; 8.
-
Dimitriadis I, Pagidas K, Vaughan D, Kim YB. Mitotically Active Leiomyoma in a Woman with Mayer-Rokitansky-K?ster-Hauser Syndrome: A Case Report. J Reprod Med. 2016 May-Jun; 61(5-6):299-301.
-
Batt RE, Yeh J. The cavitated accessory uterine mass: a M?llerian anomaly in women with an otherwise normal uterus. Obstet Gynecol. 2011 Mar; 117(3):733-734.
-
Kandil DH, MacLennan GT. M?llerian lesions of the bladder. J Urol. 2004 Nov; 172(5 Pt 1):2002.
-
Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, Gustafson ML, Chang YC, MacLaughlin DT. Measurements of serum m?llerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med. 1997 May 22; 336(21):1480-6.
-
Lee MM, Gustafson ML, Ukiyama E, Donahoe PK, MacLaughlin DT, Wexler M, Keeping HS. Developmental changes in mullerian inhibiting substance in the cynomolgus monkey, Macaca fascicularis. J Clin Endocrinol Metab. 1994 Mar; 78(3):615-21.
-
Gustafson ML, Lee MM, Asmundson L, MacLaughlin DT, Donahoe PK. M?llerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities. J Pediatr Surg. 1993 Mar; 28(3):439-44.
-
Kim JH, Seibel MM, MacLaughlin DT, Donahoe PK, Ransil BJ, Hametz PA, Richards CJ. The inhibitory effects of m?llerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells. J Clin Endocrinol Metab. 1992 Sep; 75(3):911-7.
-
Gustafson ML, Lee MM, Scully RE, Moncure AC, Hirakawa T, Goodman A, Muntz HG, Donahoe PK, MacLaughlin DT, Fuller AF. M?llerian inhibiting substance as a marker for ovarian sex-cord tumor. N Engl J Med. 1992 Feb 13; 326(7):466-71.